202 related articles for article (PubMed ID: 33214601)
1. Dopamine receptor D1- and D2-agonists do not spark brown adipose tissue thermogenesis in mice.
Raffaelli FM; Resch J; Oelkrug R; Iwen KA; Mittag J
Sci Rep; 2020 Nov; 10(1):20203. PubMed ID: 33214601
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptor stimulation inhibits cold-initiated thermogenesis in brown adipose tissue in conscious rats.
Ootsuka Y; Heidbreder CA; Hagan JJ; Blessing WW
Neuroscience; 2007 Jun; 147(1):127-35. PubMed ID: 17512675
[TBL] [Abstract][Full Text] [Related]
3. Activating dopamine D2 receptors reduces brown adipose tissue thermogenesis induced by psychological stress and by activation of the lateral habenula.
Brizuela M; Antipov A; Blessing WW; Ootsuka Y
Sci Rep; 2019 Dec; 9(1):19512. PubMed ID: 31862967
[TBL] [Abstract][Full Text] [Related]
4. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
5. Is clozapine an (partial) agonist at both dopamine D1 and D2 receptors?
Jackson DM; Wikström H; Liao Y
Psychopharmacology (Berl); 1998 Jul; 138(2):213-6. PubMed ID: 9718292
[No Abstract] [Full Text] [Related]
6. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
7. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
Zackheim JA; Abercrombie ED
Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats.
Kuo DY
J Biomed Sci; 2002; 9(2):126-32. PubMed ID: 11914579
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor 2 downregulation and brain-derived neurotrophic factor upregulation in the paraventricular nucleus are correlated with brown adipose tissue thermogenesis in rats with bilateral substantia nigra lesions.
Zhang Y; Zhou L; Lian H; Zhang Y; Tong S; Wang Z
J Chem Neuroanat; 2021 Nov; 117():102016. PubMed ID: 34454019
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
12. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
[TBL] [Abstract][Full Text] [Related]
13. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
14. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
Kamei H; Kameyama T; Nabeshima T
Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
[TBL] [Abstract][Full Text] [Related]
15. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
16. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
Garrett BE; Holtzman SG
Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Postnatal Neurogenesis by Perinatal Asphyxia: Effect of D
Tapia-Bustos A; Perez-Lobos R; Vío V; Lespay-Rebolledo C; Palacios E; Chiti-Morales A; Bustamante D; Herrera-Marschitz M; Morales P
Neurotox Res; 2017 Jan; 31(1):109-121. PubMed ID: 27638511
[TBL] [Abstract][Full Text] [Related]
18. [Functional interplay of dopamine D1 and D2 receptors in the immune response control in different psychoemotional states].
Al'perina EL; Gevorgian MM
Eksp Klin Farmakol; 2010 Jun; 73(6):2-4. PubMed ID: 20726342
[TBL] [Abstract][Full Text] [Related]
19. Working memory span capacity improved by a D2 but not D1 receptor family agonist.
Tarantino IS; Sharp RF; Geyer MA; Meves JM; Young JW
Behav Brain Res; 2011 Jun; 219(2):181-8. PubMed ID: 21232557
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Ohta K; Kuno S; Mizuta I; Fujinami A; Matsui H; Ohta M
Life Sci; 2003 Jun; 73(5):617-26. PubMed ID: 12770616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
